Hirschl R B, Heiss K F, Bartlett R H
Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0331.
J Pediatr Surg. 1992 Jan;27(1):48-53. doi: 10.1016/0022-3468(92)90103-e.
Of the 102 neonates with respiratory failure supported with extracorporeal membrane oxygenation (ECMO) at this institution between 1984 and 1987, 8 patients developed severe myocardial dysfunction that was noted shortly after onset of bypass. The neonates in the cardiac dysfunction group were more hypoxic (average PaO2 = 26 +/- 8 mm Hg v 41 +/- 19 mm Hg, P less than .01) in the immediate pre-ECMO period. Seventy-five percent were unstable hemodynamically (6 hypotensive, 3 bradycardic, 2 sustained cardiac arrest, 4 required epinephrine pressor support). On ECMO, 5 of the 8 neonates developed an ischemic cardiomyopathy that lasted for less than 24 hours and resolved without therapeutic intervention. In the other 3 cases, prolonged periods of dysfunction were noted and afterload reduction through administration of tolazoline or hydralazine was beneficial. These 8 patients serve to demonstrate the reversible nature of postischemic cardiac dysfunction in patients on ECMO and in the neonatal population in general.
1984年至1987年间,在本机构接受体外膜肺氧合(ECMO)支持的102例呼吸衰竭新生儿中,有8例在体外循环开始后不久出现严重心肌功能障碍。心脏功能障碍组的新生儿在ECMO治疗前即刻的缺氧情况更严重(平均动脉血氧分压[PaO2]为26±8毫米汞柱,而对照组为41±19毫米汞柱,P<0.01)。75%的患儿血流动力学不稳定(6例低血压,3例心动过缓,2例持续性心脏骤停,4例需要肾上腺素升压支持)。在ECMO治疗期间,8例新生儿中有5例出现持续时间不到24小时的缺血性心肌病,且未经治疗干预即自行缓解。在另外3例中,观察到心肌功能障碍持续时间延长,通过给予妥拉唑啉或肼屈嗪降低后负荷有益。这8例患者证明了ECMO治疗患者及一般新生儿群体中缺血后心脏功能障碍的可逆性。